drugset / Trial / NCT00236015
A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD).
Timeline
- Start
- 2004-11
- Primary completion
- —
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tiagabine | Small molecule | 4 mg | — |
| Subject | Tiagabine | Small molecule | 8 mg | — |
| Subject | Tiagabine | Small molecule | 12 mg | — |